Page last updated: 2024-10-23

bunazosin and Glaucoma, Suspect

bunazosin has been researched along with Glaucoma, Suspect in 1 studies

bunazosin: structure

Research Excerpts

ExcerptRelevanceReference
"We have constructed a new ocular pharmacokinetic pharmacodynamic (PK/PD) model for anti-glaucoma drugs to describe ocular hypotensive effects on intraocular pressure (IOP) after instillation of a combination of an alpha(1)-adrenergic antagonist, bunazosin, and a beta-adrenergic antagonist, timolol, into rabbits."3.74Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs. ( Higuchi, S; Kawazu, K; Kitahara, T; Nakamura, J; Nakashima, M; Nishida, K; Sakanaka, K; Sasaki, H; Tomonari, M, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakanaka, K1
Kawazu, K1
Tomonari, M1
Kitahara, T1
Nakashima, M1
Nishida, K1
Nakamura, J1
Sasaki, H1
Higuchi, S1

Other Studies

1 other study available for bunazosin and Glaucoma, Suspect

ArticleYear
Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
    Biological & pharmaceutical bulletin, 2008, Volume: 31, Issue:8

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Algorithms; Animals; Aqueous Humor; Drug

2008